(Q40925654)

24 September 2017

1 reference

title

Overview of the management of AIDS-related Kaposi's sarcoma (English)

1 reference

24 September 2017

A K Morris

1

1 reference

24 September 2017

A W Valley

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

Annals of Pharmacotherapy

24 September 2017

published in

1 reference

24 September 2017

volume

30

1 reference

24 September 2017

issue

10

1 reference

24 September 2017

page(s)

1150-1163

1 reference

Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

The epidemiology of AIDS-related Kaposi's sarcoma in San Francisco

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Kaposi's sarcoma: its ‘oncogenes’ and growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Treatment of oral Kaposi sarcoma with intralesional vinblastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Interferon administered intralesionally in skin and oral cavity lesions in heterosexual drug addicted patients with AIDS-related Kaposi's sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

A phase I trial of recombinant human interferon-gamma in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Interferon therapy for Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Phase II study of teniposide in patients with AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Treatment of the acquired immune deficiency syndrome—related Kaposi's sarcoma with bleomycin as a single agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Treatment of HIV-associated Kaposi's sarcoma with paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

Synergistic interaction of 2',3'-dideoxycytidine and recombinant interferon-alpha-A on replication of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001015

10.1177/106002809603001015

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference